(R)-2-(4-hydroxybicyclo[2.2.2]octan-1-yl)-8-methyl-4-propyl-7,8-dihydro-1H-imidazo[1,2-g]purin-5(4H)-one

ID: ALA384279

PubChem CID: 135428628

Max Phase: Preclinical

Molecular Formula: C19H27N5O2

Molecular Weight: 357.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCN1C(=O)N2C[C@@H](C)N=C2c2[nH]c(C34CCC(O)(CC3)CC4)nc21

Standard InChI:  InChI=1S/C19H27N5O2/c1-3-10-23-15-13(14-20-12(2)11-24(14)17(23)25)21-16(22-15)18-4-7-19(26,8-5-18)9-6-18/h12,26H,3-11H2,1-2H3,(H,21,22)/t12-,18?,19?/m1/s1

Standard InChI Key:  OWEIZFWQMOUOHL-PIHIASKNSA-N

Molfile:  

     RDKit          2D

 26 30  0  0  1  0  0  0  0  0999 V2000
   -3.7958   -9.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0838   -9.5333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3718   -8.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3718   -9.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5862   -9.3814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1006   -8.7131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5862   -8.0448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7919   -8.2977    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0838   -7.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2591   -7.0818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0756   -7.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4048   -7.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0843  -10.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7989  -10.7705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5132  -10.3576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2756   -8.7131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1342   -9.4347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9556   -9.4367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720   -8.7241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9607   -8.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1331   -8.0041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5708   -8.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5708   -9.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5107   -9.5368    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1958   -8.7208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4924   -6.2888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12  8  1  0
  3  9  1  0
  2 13  1  0
  4  5  1  0
 13 14  1  0
  5  6  2  0
 14 15  1  0
  6  7  1  0
  6 16  1  0
 16 17  1  0
  7  3  1  0
  8  9  1  0
  3  4  2  0
  8  1  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  1  2  1  0
 16 22  1  0
  2  4  1  0
 22 23  1  0
 23 19  1  0
  9 10  2  0
  1 24  2  0
 10 11  1  0
 19 25  1  0
 11 12  1  0
 11 26  1  1
M  END

Alternative Forms

  1. Parent:

    ALA384279

    ---

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2a (250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2b (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (3360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 357.46Molecular Weight (Monoisotopic): 357.2165AlogP: 2.55#Rotatable Bonds: 3
Polar Surface Area: 84.82Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.29CX Basic pKa: 5.11CX LogP: 1.89CX LogD: 1.89
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.87Np Likeness Score: 0.01

References

1. Vu CB, Kiesman WF, Conlon PR, Lin KC, Tam M, Petter RC, Smits G, Lutterodt F, Jin X, Chen L, Zhang J..  (2006)  Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.,  49  (24): [PMID:17125265] [10.1021/jm060539t]

Source